Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

This page is no longer being updated and the information may be out of date.

Day 1 - Gene Delivery Systems Public Workshop

Wednesday, November 1, 2023 – 8:30 am to 5:00 pm ET

Agenda

 

Time (ET) Topics

8:30 – 8:45 am 

Welcome & Opening Remarks

  • Charles Romine, Associate Director for Laboratory Programs (NIST)
  • Heather Lombardi, Director, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, CBER (FDA)

8:45 – 9:35 am

Workshop Overview

  • "NIST Role in Standards for Emerging Biotechnology and advanced therapy" – Sheng Lin-Gibson (NIST)
  • “Standards Recognition Program for Regenerative Medicine Therapies”Judy Arcidiacono (FDA)
  • “Regulatory perspective: CMC considerations for viral vectors” – Anurag Sharma (FDA)
  • "NIST efforts on Gene Delivery Systems and ISO standards" – Ed Kwee (NIST)

9:35 – 10:05 am

 

Complementary Programs

  • “Accelerating Medicines Partnership Program – Bespoke Gene Therapy Consortium” – Courtney Silverthorn (FNIH)
  • “NIIMBL Program in Viral Vector Manufacturing and Analytics” – Kelvin Lee (NIIMBL)

10:05 – 10:20 am

Break

10:20 – 11:35 am

 

Common challenges and difference of gene delivery systems and ongoing efforts

  • “Enabling Affordable and Accessible Advanced Medicines” – Boro Dropulic (Caring Cross)
  • “Common Analytical Challenges with Adeno Associated Virus Mediated Gene Therapy” - Will Fountain (Andelyn Bioscience)
  • Analytical Challenges Associated with Lipid Nanoparticle mediated Gene Delivery and Gene Editing” – Carl Co (Arbor Bio)
  • “Extracellular Vesicles (EVs) as a Novel Drug Delivery Platform" – Haiying Zhang (Weill Cornell Medical)
  • Analytical challenges for adenovirus-based vectorsNancy Sajjadi (Sajjadi Consulting)

11:35 am – 12:00 pm             

Panel Discussion – commonalities and differences

12:00 – 1:00 pm

Lunch Break

1:00 – 2:10 pm

Breakout Sessions (in-person only)

  • Viral vector functional measurements
  • Viral vector physical measurements
  • Non-viral vector functional measurements
  • Non-viral vector physical measurements

2:10 – 2:30 pm

Break

2:30 – 4:30 pm

 

New Technology Showcase (Measurements and Systems)

  • “NibaPlex® assay platform for AAV vector genome integrity quantification” David Dobnik (Niba Labs)
  • “Viral vector capsid characterization using mass photometry”Gabriella Kiss (Refeyn)
  • How super resolution can helps you gain better insights into your samples”  –Ricardo Nunes Bastos (Oni)
  • “Image cytometry technology and applications for viral infectivity/transduction analysis” - Bo Lin (Revvity)
  • “Label-free single cell PAT precision analytics for cell and gene therapies and vaccines” - Renee Hart (Lumacyte)
  • “Insights into LNP quantification and their therapeutic application”- Carsten Russ (Intellia)
  • “Focused ultrasound modulation of the blood-brain-barrier permeability for delivery of gene therapy to the brain” - Frederic Padilla (Focused Ultrasound Foundation)
  • “Therapeutic Applications of Novel Q5 Exosomes” - Javed Siddiqi (Exom BioPharma)

4:30 – 5:00 pm

Closing

  • Report of breakout sessions
  • Summary with polling
  • Next Steps for NIST Gene Delivery Systems Working Group and opportunities for participation.

Jamie Almeida (NIST)

5:00 pm

Adjourn

Created September 6, 2023, Updated February 3, 2026
Was this page helpful?